Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation.

[1]  J. Orens,et al.  Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. , 2007, American journal of respiratory and critical care medicine.

[2]  M. Zorzetto,et al.  The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? , 2006, Modern Pathology.

[3]  M. Matthay,et al.  Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. , 2006, American journal of respiratory and critical care medicine.

[4]  L. Moldawer,et al.  Cytokine profile after lung transplantation: correlation with allograft injury. , 2006, The Annals of thoracic surgery.

[5]  L. Jain,et al.  Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Stephen E Kimmel,et al.  The effect of primary graft dysfunction on survival after lung transplantation. , 2005, American journal of respiratory and critical care medicine.

[8]  P. Dartevelle,et al.  Graft ischemic time and outcome of lung transplantation: a multicenter analysis. , 2005, American journal of respiratory and critical care medicine.

[9]  G. Bernard,et al.  Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.

[10]  S. Kimmel,et al.  Impact of primary graft failure on outcomes following lung transplantation. , 2005, Chest.

[11]  P. Parsons,et al.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[12]  N. Kohno,et al.  Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[13]  E. Schleicher,et al.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.

[14]  T. Evans,et al.  KL‐6 levels are elevated in plasma from patients with acute respiratory distress syndrome , 2004, European Respiratory Journal.

[15]  Stefan Fischer,et al.  Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  P. Parsons,et al.  Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury , 2003, Thorax.

[17]  M. Matthay,et al.  Protein C and thrombomodulin in human acute lung injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[18]  D. Glidden,et al.  Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation* , 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  M. Matthay,et al.  Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[20]  Marshall Hertz,et al.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  Stefan Fischer,et al.  Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. , 2002, American journal of respiratory and critical care medicine.

[22]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[23]  Z. Makita,et al.  Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease , 2001, Brain Research.

[24]  E. Mascha,et al.  Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. , 1999, Chest.

[25]  M. Matthay,et al.  Identification of patients with acute lung injury. Predictors of mortality. , 1995, American journal of respiratory and critical care medicine.

[26]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[27]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[28]  B. Griffith,et al.  Interleukin-6, a marker of preservation injury in clinical lung transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.